- Home
- ATIF vs BMRA Comparison
ATIF vs BMRA Comparison
Compare ATIF & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATIF
- BMRA
- Stock Information
- Founded
- ATIF 2015
- BMRA 1971
- Country
- ATIF United States
- BMRA United States
- Employees
- ATIF N/A
- BMRA N/A
- Industry
- ATIF Professional Services
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ATIF Consumer Discretionary
- BMRA Health Care
- Exchange
- ATIF Nasdaq
- BMRA Nasdaq
- Market Cap
- ATIF 9.8M
- BMRA 7.4M
- IPO Year
- ATIF 2019
- BMRA N/A
- Fundamental
- Price
- ATIF $0.86
- BMRA $0.33
- Analyst Decision
- ATIF
- BMRA
- Analyst Count
- ATIF 0
- BMRA 0
- Target Price
- ATIF N/A
- BMRA N/A
- AVG Volume (30 Days)
- ATIF 214.7K
- BMRA 68.2K
- Earning Date
- ATIF 12-13-2024
- BMRA 10-15-2024
- Dividend Yield
- ATIF N/A
- BMRA N/A
- EPS Growth
- ATIF N/A
- BMRA N/A
- EPS
- ATIF N/A
- BMRA N/A
- Revenue
- ATIF $500,000.00
- BMRA $5,509,000.00
- Revenue This Year
- ATIF N/A
- BMRA N/A
- Revenue Next Year
- ATIF N/A
- BMRA N/A
- P/E Ratio
- ATIF N/A
- BMRA N/A
- Revenue Growth
- ATIF N/A
- BMRA 1.74
- 52 Week Low
- ATIF $0.58
- BMRA $0.24
- 52 Week High
- ATIF $1.50
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- ATIF 46.75
- BMRA 47.85
- Support Level
- ATIF $0.85
- BMRA $0.28
- Resistance Level
- ATIF $1.50
- BMRA $0.35
- Average True Range (ATR)
- ATIF 0.18
- BMRA 0.04
- MACD
- ATIF -0.01
- BMRA 0.00
- Stochastic Oscillator
- ATIF 15.82
- BMRA 41.67
About ATIF ATIF Holdings Limited
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.